How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study

Y Liu, J Zhu, X Guo, T Huang, J Han, J Gao… - Journal of …, 2020 - Taylor & Francis
Approximately 30% of all types of human cancers possess a constitutively activated the
mitogen-activated protein kinase (MAPK) signaling pathway while MAP kinase 1 (MEK1) is a …
被引用次数：11 相关文章

How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study.

Y Liu, J Zhu, X Guo, T Huang, J Han, J Gao… - … Structure & Dynamics, 2019 - europepmc.org
Approximately 30% of all types of human cancers possess a constitutively activated the
mitogen-activated protein kinase (MAPK) signaling pathway while MAP kinase 1 (MEK1) is a …

How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study

Y Liu, J Zhu, X Guo, T Huang, J Han… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Approximately 30% of all types of human cancers possess a constitutively activated the
mitogen-activated protein kinase (MAPK) signaling pathway while MAP kinase 1 (MEK1) is a …

How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study

Y Liu, J Zhu, X Guo, T Huang, J Han… - Journal of …, 2020 - ingentaconnect.com
Approximately 30% of all types of human cancers possess a constitutively activated the
mitogen-activated protein kinase (MAPK) signaling pathway while MAP kinase 1 (MEK1) is a …
[HTML] nih.gov

[HTML][HTML] How oncogenic mutations activate human MAP kinase 1 (MEK1): A molecular dynamics simulation study

Y Liu, J Zhu, X Guo, T Huang, J Han, J Gao… - … structure & dynamics, 2020 - ncbi.nlm.nih.gov
Approximately 30% of all types of human cancers possess a constitutively activated the
mitogen-activated protein kinase (MAPK) signaling pathway while MAP kinase 1 (MEK1) is a …